Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

BIOPREDIC INTERNATIONAL : revenue, balance sheet and financial ratios

BIOPREDIC INTERNATIONAL is a French company founded 32 years ago, specialized in the sector Fabrication de préparations pharmaceutiques. Based in SAINT-GREGOIRE (35760), this company of category PME shows in 2023 a net income positive of 510 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - BIOPREDIC INTERNATIONAL (SIREN 391701232)
Indicator 2023 2022 2021 2020 2017
Revenue N/C N/C N/C N/C N/C
Net income 509 729 € 401 279 € -59 516 € -216 174 € 150 355 €
EBITDA N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C

Revenue and income statement

In 2023, BIOPREDIC INTERNATIONAL generates positive net income of 510 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 150 k€ -> 510 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

509 729 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 6%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

5.971%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

69.172%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

0.2%

Solvency indicators evolution
BIOPREDIC INTERNATIONAL

Sector positioning

Debt ratio
5.97 2023
2021
2022
2023
Q1: 0.0
Med: 2.28
Q3: 51.98
Average

In 2023, the debt ratio of BIOPREDIC INTERNATIONAL (5.97) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
69.17% 2023
2021
2022
2023
Q1: 25.54%
Med: 52.2%
Q3: 68.87%
Excellent

In 2023, the financial autonomy of BIOPREDIC INTERNATIONAL (69.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 428.75. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

428.745

Liquidity indicators evolution
BIOPREDIC INTERNATIONAL

Sector positioning

Liquidity ratio
428.75 2023
2021
2022
2023
Q1: 112.83
Med: 200.61
Q3: 363.19
Excellent

In 2023, the liquidity ratio of BIOPREDIC INTERNATIONAL (428.75) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of BIOPREDIC INTERNATIONAL in its sector

Comparison with sector Fabrication de préparations pharmaceutiques

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (27 transactions). This range of 101 700€ to 312 588€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2023
Indicative
101k€ 229k€ 312k€
229 610 € Range: 101 700€ - 312 588€
NAF 5 all-time
How is this estimate calculated?

This estimate is based on the analysis of 27 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication de préparations pharmaceutiques)

Compare BIOPREDIC INTERNATIONAL with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de préparations pharmaceutiques

Frequently asked questions about BIOPREDIC INTERNATIONAL

What is the revenue of BIOPREDIC INTERNATIONAL ?

The revenue of BIOPREDIC INTERNATIONAL is not publicly disclosed (confidential accounts filed with INPI).

Is BIOPREDIC INTERNATIONAL profitable?

Yes, BIOPREDIC INTERNATIONAL generated a net profit of 510 k€ in 2023.

Where is the headquarters of BIOPREDIC INTERNATIONAL ?

The headquarters of BIOPREDIC INTERNATIONAL is located in SAINT-GREGOIRE (35760), in the department Ille-et-Vilaine.

Where to find the tax return of BIOPREDIC INTERNATIONAL ?

The tax return of BIOPREDIC INTERNATIONAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does BIOPREDIC INTERNATIONAL operate?

BIOPREDIC INTERNATIONAL operates in the sector Fabrication de préparations pharmaceutiques (NAF code 21.20Z). See the 'Sector positioning' section above to compare the company with its competitors.